Whats the regulatory status
So it can't be said for certain if his idea was right or wrong
For neurodegenerative applications, a combination of Dihexa (synaptogenesis), Cerebrolysin (broad neurotrophic support), and Pinealon (epigenetic neuroprotection) addresses connectivity loss, growth factor deficiency, and oxidative vulnerability in parallel
When my barrier is off, everything looks worse: texture, pores, redness, even glow
The availability of a peptide through a licensed pharmacy does not necessarily mean that the peptide or its intended use is FDA-approved, nor does it establish safety or effectiveness for every patient or medical condition